Advanced imaging and AI for detecting and staging osteoporosis and osteoarthritis
Official title: A Comprehensive Evaluation of Musculoskeletal Aging and Degenerative Pathologies Using Multi-modal Clinical Imaging and Quantitative Analysis.
Run by Peking University People's Hospital · NCT07474571 · Data updated 2026-11-12
This project will see if an AI system can use routine X‑rays, CT, and MRI to accurately diagnose and stage osteoporosis and osteoarthritis in adults.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 2000 (estimated) |
| Sponsor | Peking University People's Hospital Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Beijing) |
| Status | Recruiting |
| Started | November 1, 2005 |
| Main results expected | December 1, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | March 19, 2026 |
| Trial ID | NCT07474571 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults (18–90) who have completed relevant clinical imaging (X‑ray, CT, or MRI) of bone or joint sites and have no implants or major skeletal deformities.
✕Probably not a fit
Patients with prior pathological fractures, active bone malignancy, recent chemotherapy or radiotherapy, or a history of long‑term steroid use are excluded and unlikely to benefit from the model's outputs.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational project develops and validates a multimodal AI platform that combines X‑ray, CT, MRI, clinical laboratory markers, and patient history to detect and stage osteoporosis and osteoarthritis. A retrospective cohort of about 1,500 patients from Peking University People's Hospital (2005–2025) will be used for model development, and at least 500 prospectively recruited adults will provide external validation beginning December 2025. The AI will quantify bone mineral density and microarchitecture for osteoporosis and identify radiographic markers such as joint space narrowing and osteophytes for osteoarthritis to produce standardized staging. The work is non‑interventional and aims to reduce inter‑observer variability and improve objectivity in imaging-based musculoskeletal assessment.
Why it matters
Potential benefit: If successful, the platform could provide faster, more objective, and more consistent diagnoses and staging of osteoporosis and osteoarthritis, helping clinicians make better treatment and fracture‑risk decisions.
How similar studies have gone: Similar AI methods have shown promising results for automated bone density measurement and radiographic OA grading in earlier studies, but the combination of multimodal imaging and large prospective validation remains relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age: Adults aged at least 18 years. * Gender: No gender restrictions; both male and female participants are eligible. * Imaging Data: Participants must have completed relevant clinical imaging scans of skeletal sites, including but not limited to X-ray, CT (plain scan), or MRI (plain scan). * Anatomical Integrity: The skeletal structure of the target area must be free from congenital or acquired deformities. * Absence of Implants: No internal fixation materials or orthopedic implants in the skeletal areas being assessed. Exclusion Criteria: * Pathological History: Patients with a history of prior pathological fractures. * Malignancy: Patients seeking treatment or diagnosed with bone tumors or other systemic malignancies. * Medication History: Patients with a history of long-term steroid use, which may significantly affect bone density and joint structure. * Recent Treatment: Patients who have undergone radiotherapy or chemotherapy within the past six months. * Data Quality: Patients whose imaging data is of insufficient quality for AI analysis or lacks clear clinical diagnostic "gold standard" references (e.g., missing DXA results for osteoporosis staging).
Where it's running
- Beijing, China Recruiting
Study contacts
- Study coordinator: Yuhui Kou, M.D
- Email: yuhuikou@bjmu.edu.cn
- Phone: 13146213332
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Role of LH and hCG in adults being evaluated for endocrine disorders
This study looks at whether levels of luteinizing hormone (LH) and hCG in adults undergoing endocrine evaluation relate to their disease presence and outcomes.
-
Medial knee osteoarthritis: inside vs outside corticosteroid injection
This study tests whether injecting a steroid inside the knee joint leads to different pain results than injecting it on the outside of the knee in people with medial knee osteoarthritis.
-
Genicular Artery Embolization for Severe Knee Osteoarthritis Pain
This trial tests whether blocking blood flow to knee arteries can reduce persistent pain in adults with severe knee osteoarthritis who have not improved with standard care.
-
Low Dose Radiotherapy for Osteoarthritis
This study tests whether low-dose radiotherapy can help reduce pain and improve function for adults with osteoarthritis who have not benefited from standard treatments.
-
Can a blood marker called lumican reveal hidden fragility in postmenopausal osteoporosis
This study tests whether serum lumican levels can help identify hidden fragility risk in postmenopausal women beyond what bone density shows.
-
Functional Muscle-Bone Incongruity Index: A look at muscle strength and bone health in adults
This observational study tests a composite FKUI score using handgrip strength and hip/spine bone density to see if it better reflects musculoskeletal health than each measure alone in adults undergoing routine DXA.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.